DAPIROLIZUMAB PEGOL

UNII: N4606MB5HM
Preferred Substance Name: DAPIROLIZUMAB PEGOL

1416147-64-2
CDP-7657
DAPIROLIZUMAB PEGOL [INN]
DAPIROLIZUMAB PEGOL [WHO-DD]
IMMUNOGLOBULIN FAB' G1-KAPPA PEGYLATED, ANTI-(HOMO SAPIENS CD40LG (CD40 LIGAND, CD40L, TUMOR NECROSIS FACTOR LIGAND SUPERFAMILY MEMBER 5, TNFSF5, TUMOR NECROSIS FACTOR RELATED ACTIVATION PROTEIN, TRAP, CD154)), PEGYLATED HUMANIZED MONOCLONAL ANTIBODY

Note

UNIIs are generated based on scientific identity characteristics using ISO 11238 data elements. UNII availability does not imply any regulatory review or approval. Synonyms and mappings are based on the best public information available at the time of publication. Please report any problems/errors associated with this data to FDA-SRS@fda.hhs.gov.

About, Contact Us, Copyright, Privacy, Accessibility

U.S. Food and Drug Administration, 10903 New Hampshire Ave, Silver Spring, MD 20993-0002

U.S. Food and Drug Administration, Health & Human Services

Freedom of Information Act

DAPIROLIZUMAB PEGOL

Synonyms and Mappings

Resources

Note